Filing Details
- Accession Number:
- 0001708138-20-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-16 16:03:34
- Reporting Period:
- 2020-04-14
- Accepted Time:
- 2020-04-16 16:03:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-14 | 3,500 | $272.70 | 27,873 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-14 | 2,647 | $521.45 | 25,226 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-04-15 | 54 | $516.89 | 25,172 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 304 | $517.84 | 24,868 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 287 | $518.31 | 24,581 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 76 | $519.58 | 24,505 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 130 | $520.36 | 24,375 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 2 | $525.30 | 24,373 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-14 | 3,500 | $0.00 | 3,500 | $272.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 35,500 | 2023-09-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 200 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 304 shares of Company stock on April 15, 2020 at prices ranging from $517.62 to $517.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- Represents volume-weighted average price of sales of 287 shares of Company stock on April 15, 2020 at prices ranging from $518.01 to $518.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- Represents volume-weighted average price of sales of 76 shares of Company stock on April 15, 2020 at prices ranging from $519.27 to $519.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- Represents volume-weighted average price of sales of 130 shares of Company stock on April 15, 2020 at prices ranging from $520.15 to $520.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
